The clinical and microbiological efficacy of a zinc-citrate/hydroxyapatite/potassium-citrate containing toothpaste: a double-blind randomized controlled clinical trial
Clinical Oral Investigations · 2024
DOI: 10.1007/s00784-024-06052-z ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Investigations, 2024. Verfasst von Uros Josic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department for Biomedical and Neuromotor Sciences, DIBINEM, University of Bologna, Via San Vitale 59, 40125, Bologna, Italy. Hauptthemen laut MEDLINE: Toothpastes, Durapatite, Streptococcus mutans, Fluorides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the antibacterial efficacy of two fluoride-containing (1450 ppm F) toothpastes with or without zinc-citrate (ZCT), hydroxyapatite (HAP) and potassium-citrate (KCit); to assess and compare their clinical effects in terms of tooth sensitivity, plaque accumulation and gingivitis, as well as patients’ satisfaction. Materials and methods Healthy, adult patients were selected and randomly assigned to two groups ( n = 50): Experimental: ZCT-, HAP-, KCit- and fluoride-containing toothpaste; Control: fluoride-containing toothpaste. Salivary counts of Streptococcus mutans (S. mutans) , plaque and gingival index, as well as clinically diagnosed sensitivity were recorded at baseline, and after 4 weeks. A custom-made questionnaire was used to assess patients’ self-reported sensitivity (baseline and after 4 weeks) and overall satisfaction with the tested toothpastes. Data were statistically analyzed (α = 0.05).
Results
After 4 weeks, a statistically significant salivary reduction of S. mutans was observed in both groups ( p = 0.001). Furthermore, the percentage of S. mutans decrease was significantly higher in Experimental group ( p = 0.014). There were no statistically significant differences between the groups in terms of plaque and gingival index ( p > 0.05). After 4 weeks, the self-reported tooth sensitivity was lower in Experimental group ( p < 0.001).
Conclusions
Both toothpastes showed good antimicrobial effect after 4 weeks; however, the toothpaste containing ZCT, HAP, KCit and fluoride was found to be more effective in reducing the salivary counts of S. mutans than the product containing fluoride alone. Clinical relevance Toothpaste containing ZCT, HAP, KCit and fluoride can be recommended for patients at risk for developing caries and may also be beneficial for individuals experiencing dental sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Biomedical and Neuromotor Sciences, DIBINEM, University of Bologna, Via San Vitale 59, 40125, Bologna, Italy.
- Department for Biomedical and Neuromotor Sciences, DIBINEM, University of Bologna, Via San Vitale 59, 40125, Bologna, Italy. lorenzo.breschi@unibo.it.
Zitieren
APA
Josic, U., Maravic, T., Mazzitelli, C., Rinaldi, L., D'Alessandro, C., D'Urso, D., Pellegrino, G., Mazzoni, A., & Breschi, L. (2024). The clinical and microbiological efficacy of a zinc-citrate/hydroxyapatite/potassium-citrate containing toothpaste: a double-blind randomized controlled clinical trial. Clinical Oral Investigations. https://doi.org/10.1007/s00784-024-06052-z
Vancouver
Josic U, Maravic T, Mazzitelli C, Rinaldi L, D'Alessandro C, D'Urso D, et al. The clinical and microbiological efficacy of a zinc-citrate/hydroxyapatite/potassium-citrate containing toothpaste: a double-blind randomized controlled clinical trial. Clinical Oral Investigations. 2024. doi:10.1007/s00784-024-06052-z
BibTeX
@article{Josic2024,
author = {Josic, Uros and Maravic, Tatjana and Mazzitelli, Claudia and Rinaldi, Lorenzo and D'Alessandro, Carlo and D'Urso, Diego and Pellegrino, Gerardo and Mazzoni, Annalisa and Breschi, Lorenzo},
title = {The clinical and microbiological efficacy of a zinc-citrate/hydroxyapatite/potassium-citrate containing toothpaste: a double-blind randomized controlled clinical trial},
journal = {Clinical Oral Investigations},
year = {2024},
doi = {10.1007/s00784-024-06052-z}
}
EUVIMED